Platelet-to-lymphocyte ratio better predicts inflammation than neutrophil-to-lymphocyte ratio in end-stage renal disease patients.

K, Turkmen; FM, Erdur; F, Ozcicek; A, Ozcicek; EM, Akbas; A, Ozbicer; L, Demirtas; S, Turk; HZ, Tonbul

doi:10.1111/hdi.12040

Public

Platelet-to-lymphocyte ratio better predicts inflammation than neutrophil-to-lymphocyte ratio in end-stage renal disease patients.

Shared by NobleBlocks on Mar 24, 2013 • 12:00 AM UTC

Authors:

Turkmen K

Erdur FM

Ozcicek F

Abstract

Neutrophil-to-lymphocyte ratio (NLR) was introduced as a potential marker to determine inflammation in end-stage renal disease (ESRD) patients. Recently, platelet-to-lymphocyte ratio (PLR) and NLR were found to positively correlated with inflammatory markers including tumor necrosis factor-α (TNF-α)...

Discussions